Kimberly-Clark Corp (KMB) has seen a notable increase in short interest, with investors receiving a 14% return over the past year. The company has raised its 2024 outlook following the announcement of its first and second quarter results. While analysts give KMB an average recommendation of 'Hold',
Swedbank AB and
M&G Plc have increased their shareholdings. Despite this, shares have been sold by key insiders, including the
President of Latin America Gonzalo Uribe and
Vice President and Controller Andrew Drexler. The appointment of
Craig Slavtcheff as Chief Research and Development Officer, and
Patricia Corsi as Chief Growth Officer, are seen as positive momentum drivers. Despite weaker tissue demand impacting earnings and a decrease in share price post Q1 Earnings, the stock seems fairly valued at $135. Even with the stock down by 2.8% since the last earnings report, KMB continues to outperform the broader market and maintains its position as a favored choice among institutional investors, who currently own 79% of the company. The company's dividend continues to grow, and long-term targets have been unveiled as part of a new operating model. Finally,
Ethisphere has named Kimberly-Clark as one of the 2024 World's Most Ethical Companies®.
Kimberly-Clark Corp KMB News Analytics from Tue, 24 Oct 2023 07:00:00 GMT to Sun, 18 Aug 2024 21:16:01 GMT -
Rating 6
- Innovation 4
- Information 7
- Rumor 2
